ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

8.04%

$6.05

Market Cap $93.65M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	Annual Report to shareholders		13/10/15	1.61MB	Share
AVR	Positive CardioCel valve reconstruction data	PRICE SENSITIVE	06/10/15	312.86KB	Share
AVR	Admedus initiates collaboration on stem cell delivery	PRICE SENSITIVE	30/09/15	312.03KB	Share
AVR	Admedus initiates heart valve clinical study	PRICE SENSITIVE	23/09/15	283.38KB	Share
AVR	Admedus to present at EACTS		10/09/15	619.14KB	Share
AVR	Amedus Expands CardioCel Portfolio to Meet Surgical Needs	PRICE SENSITIVE	03/09/15	309.93KB	Share
AVR	Annual Report to shareholders and Appendix 4E	PRICE SENSITIVE	27/08/15	346.86KB	Share
AVR	Admedus HSV-2 Phase II Study Interim Update	PRICE SENSITIVE	27/08/15	315.35KB	Share
AVR	Appendix 3B		17/08/15	1.19MB	Share
AVR	Appendix 3B - Options exercised		03/08/15	1.19MB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/15	353.16KB	Share
AVR	Appendix 3B - Issue of Options		22/07/15	915.72KB	Share
AVR	CardioCel shows no evidence of calcification after 7 years	PRICE SENSITIVE	08/07/15	339.18KB	Share
AVR	Appendix 3B		01/07/15	916.2KB	Share
AVR	Appendix 3B - Exercise of Options		26/06/15	1.26MB	Share
AVR	CardioCel approval in Singapore	PRICE SENSITIVE	18/06/15	420.95KB	Share
AVR	Change of Share Registry Address		12/06/15	20.69KB	Share
AVR	Change of Registered office address		09/06/15	402.68KB	Share
AVR	Admedus HSV-2 Phase II Update	PRICE SENSITIVE	05/06/15	283.61KB	Share
AVR	New CardioCel product for vascular repair	PRICE SENSITIVE	18/05/15	277.75KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	367.14KB	Share
AVR	Change in substantial holding		28/04/15	53.19KB	Share
AVR	Top 20 Holders		23/04/15	46.22KB	Share
AVR	Appendix 3Y - Change of Directors' Interest Notice		22/04/15	364.09KB	Share
AVR	Appendix 3B - Rights Issue		22/04/15	830.43KB	Share
AVR	Admedus appoints Genpharm as CardioCel distributor in MENA	PRICE SENSITIVE	22/04/15	318.77KB	Share
AVR	Admedus completes fully subscribed Rights Issue		17/04/15	277.32KB	Share
AVR	Admedus Herpes Phase II - First dosing to commence	PRICE SENSITIVE	10/04/15	284.02KB	Share
AVR	Admedus expands market for ADAPT tissue products	PRICE SENSITIVE	07/04/15	280.41KB	Share
AVR	Section 708A(5)(e) Notice - Placement & Options		01/04/15	124.69KB	Share
AVR	Appendix 3B - Placement		01/04/15	825.17KB	Share
AVR	CardioCel to feature at prominent heart valve conferences		01/04/15	2.73MB	Share
AVR	Change in substantial holding - Minderoo		30/03/15	53.15KB	Share
AVR	Dispatch of Offer Document		30/03/15	221.8KB	Share
AVR	Rights Issue - Sample Application Form		30/03/15	438.08KB	Share
AVR	Non-Renounceable Right Issue Offer Document	PRICE SENSITIVE	30/03/15	279.86KB	Share
AVR	Letter to Shareholders		30/03/15	779.43KB	Share
AVR	Change of Director's Interest Notice		26/03/15	256.89KB	Share
AVR	Appendix 3B - Placement & Exercise of Options		25/03/15	828.48KB	Share
AVR	Non-Renounceable Right Issue Offer Document	PRICE SENSITIVE	20/03/15	561.15KB	Share
AVR	Letter to Ineligible Shareholders		20/03/15	77.23KB	Share
AVR	Letter to Eligible Shareholders		20/03/15	254.12KB	Share
AVR	Letter to Optionholders		20/03/15	321.69KB	Share
AVR	Admedus Investor Presentation		18/03/15	901.84KB	Share
AVR	Appendix 3B - Rights Issue		18/03/15	724.88KB	Share
AVR	Notice under Section 708AA		18/03/15	168.93KB	Share
AVR	Admedus announces Placement and Rights Issue	PRICE SENSITIVE	18/03/15	290.29KB	Share
AVR	Trading Halt	PRICE SENSITIVE	16/03/15	362.09KB	Share
AVR	Admedus expands CardioCel market	PRICE SENSITIVE	12/03/15	277.83KB	Share
AVR	Half Year Report	PRICE SENSITIVE	27/02/15	225.86KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	387.46KB	Share
AVR	Admedus End of Year Update	PRICE SENSITIVE	24/12/14	289.38KB	Share
AVR	Appendix 3X - Initial Director's Interest Notice		05/12/14	234.28KB	Share
AVR	HPV Vaccine Heads to the Clinic	PRICE SENSITIVE	24/11/14	299.01KB	Share
AVR	Results of Annual General Meeting		14/11/14	338.14KB	Share
AVR	AGM - Presentation to Shareholders		14/11/14	800.65KB	Share
AVR	Admedus receives Originating Process		12/11/14	295.91KB	Share
AVR	Change in substantial holding		10/11/14	1.57MB	Share
AVR	Appendix 3B - Options		05/11/14	623.7KB	Share
AVR	CardioCel gains special access in Singapore	PRICE SENSITIVE	03/11/14	339.88KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	289.96KB	Share
AVR	Cancellation of Unlisted Options		27/10/14	139.48KB	Share
AVR	Appendix 3B - Exercise Options		27/10/14	668.52KB	Share
AVR	CardioCel granted Medical Device Licence in Canada	PRICE SENSITIVE	20/10/14	291.33KB	Share
AVR	Annual Report to shareholders		14/10/14	4.43MB	Share
AVR	Proxy Form		14/10/14	329.65KB	Share
AVR	Notice of Annual General Meeting		14/10/14	173.41KB	Share
AVR	Chairman's Letter to Shareholders		14/10/14	110.83KB	Share
AVR	Admedus to showcase CardioCel at EACTS Annual Meeting		10/10/14	281.34KB	Share
AVR	Director Appointments		10/10/14	302.69KB	Share
AVR	Appendix 3B		07/10/14	668.66KB	Share
AVR	Admedus announces further data from HSV-2 Trial	PRICE SENSITIVE	02/10/14	427.97KB	Share
AVR	Becoming a substantial holder		30/09/14	1.38MB	Share
AVR	Appendix 3B		03/09/14	800.95KB	Share
AVR	Annual Report to shareholders and Appendix 4E	PRICE SENSITIVE	28/08/14	1.53MB	Share
AVR	Admedus ships CardioCel to US from new facility	PRICE SENSITIVE	14/08/14	322.99KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/14	291.14KB	Share
AVR	Admedus increases holding in Admedus Vaccines	PRICE SENSITIVE	24/07/14	342.65KB	Share
AVR	Appendix 3B - Exercise of Options		22/07/14	800.55KB	Share
AVR	Admedus End of Financial Year Update	PRICE SENSITIVE	26/06/14	353.61KB	Share
AVR	Change of Director's Interest Notice		12/06/14	230.85KB	Share
AVR	Change of Director's Interest Notices		11/06/14	274.06KB	Share
AVR	Appendix 3B - Share Purchase Plan		11/06/14	770.4KB	Share
AVR	Admedus SPP well supported		06/06/14	292.02KB	Share
AVR	Appendix 3B - Exercise of options		23/05/14	726.94KB	Share
AVR	Appendix 3B - ESOP		22/05/14	725.08KB	Share
AVR	Change in substantial holding		22/05/14	489.62KB	Share
AVR	Security Purchase Plan - Sample Application Form		19/05/14	330.23KB	Share
AVR	Security Purchase Plan		19/05/14	1.55MB	Share
AVR	Security Purchase Plan - Chairman's Letter		19/05/14	1.23MB	Share
AVR	Appendix 3B - Placement & Notice under Section 708A		19/05/14	753.75KB	Share
AVR	Admedus announces Placement and SPP	PRICE SENSITIVE	12/05/14	341.69KB	Share
AVR	Trading Halt	PRICE SENSITIVE	08/05/14	354.98KB	Share
AVR	CardioCel Sales Update - First sales order for the US	PRICE SENSITIVE	07/05/14	280.17KB	Share
AVR	CardioCel 6 year data shows no calcification	PRICE SENSITIVE	01/05/14	277.68KB	Share
AVR	AHZ 4C March 2014 quarter	PRICE SENSITIVE	24/04/14	407.37KB	Share
AVR	Appendix 3B - Options		28/03/14	734.18KB	Share
AVR	Investor Presentation		25/03/14	1.95MB	Share
AVR	Appendix 3B - Options & Notice under Section 708A		07/03/14	766.87KB	Share
AAI +PRX ADS ADO AEH CQE AFJ AGI AVR AJD ALK ALU AMX ANI AOH AQG AQP ARP PRN ASZ ATU AVG AXZ BGA BNO BOL BTR BYI CAJ CCU CLE CFU COF CPL CRH CTP CUE CVO DCG DDR DLX DML DSH DYL EAX K2P EPW EQX WJA EVR EWC FLK FLN RHK FND NOU FSA GAP GBG GBT GCS GDI ETM GHC GID GJT GNG GOW GDA GRY GUF GXY HIG HPI IAG E88 ICN ICQ IDC DXI IPP ISN JHX JPR KPL KRL KRM VBC LSA MCE MCR MCS MEO AZT LCL SYM MNW SVR MOY MPO MRP MVP MYE NCM NCR NEA NEN NEU NSE NSR NXS OFX OMH OZL PAN PBD ATH PCL PEN PGH OVT IMM QAN AX1 REA RKN RXP SAO SBB SDF SDM SEH SHJ SIV KLS SLR SMX SWL TAP TBR TFC TGP TGZ AUK UGL VAH VED VEI VET VLW VOC VTG WBA WDS XRO ZNZ ZSP	S&P DJ Indices Announces March Quarterly Rebalance		07/03/14	98KB	Share

AVR Annual Report to shareholders
13/10/15		1.61MB	Share
AVR Positive CardioCel valve reconstruction data
06/10/15	PRICE SENSITIVE	312.86KB	Share
AVR Admedus initiates collaboration on stem cell delivery
30/09/15	PRICE SENSITIVE	312.03KB	Share
AVR Admedus initiates heart valve clinical study
23/09/15	PRICE SENSITIVE	283.38KB	Share
AVR Admedus to present at EACTS
10/09/15		619.14KB	Share
AVR Amedus Expands CardioCel Portfolio to Meet Surgical Needs
03/09/15	PRICE SENSITIVE	309.93KB	Share
AVR Annual Report to shareholders and Appendix 4E
27/08/15	PRICE SENSITIVE	346.86KB	Share
AVR Admedus HSV-2 Phase II Study Interim Update
27/08/15	PRICE SENSITIVE	315.35KB	Share
AVR Appendix 3B
17/08/15		1.19MB	Share
AVR Appendix 3B - Options exercised
03/08/15		1.19MB	Share
AVR Appendix 4C - quarterly
30/07/15	PRICE SENSITIVE	353.16KB	Share
AVR Appendix 3B - Issue of Options
22/07/15		915.72KB	Share
AVR CardioCel shows no evidence of calcification after 7 years
08/07/15	PRICE SENSITIVE	339.18KB	Share
AVR Appendix 3B
01/07/15		916.2KB	Share
AVR Appendix 3B - Exercise of Options
26/06/15		1.26MB	Share
AVR CardioCel approval in Singapore
18/06/15	PRICE SENSITIVE	420.95KB	Share
AVR Change of Share Registry Address
12/06/15		20.69KB	Share
AVR Change of Registered office address
09/06/15		402.68KB	Share
AVR Admedus HSV-2 Phase II Update
05/06/15	PRICE SENSITIVE	283.61KB	Share
AVR New CardioCel product for vascular repair
18/05/15	PRICE SENSITIVE	277.75KB	Share
AVR Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	367.14KB	Share
AVR Change in substantial holding
28/04/15		53.19KB	Share
AVR Top 20 Holders
23/04/15		46.22KB	Share
AVR Appendix 3Y - Change of Directors' Interest Notice
22/04/15		364.09KB	Share
AVR Appendix 3B - Rights Issue
22/04/15		830.43KB	Share
AVR Admedus appoints Genpharm as CardioCel distributor in MENA
22/04/15	PRICE SENSITIVE	318.77KB	Share
AVR Admedus completes fully subscribed Rights Issue
17/04/15		277.32KB	Share
AVR Admedus Herpes Phase II - First dosing to commence
10/04/15	PRICE SENSITIVE	284.02KB	Share
AVR Admedus expands market for ADAPT tissue products
07/04/15	PRICE SENSITIVE	280.41KB	Share
AVR Section 708A(5)(e) Notice - Placement & Options
01/04/15		124.69KB	Share
AVR Appendix 3B - Placement
01/04/15		825.17KB	Share
AVR CardioCel to feature at prominent heart valve conferences
01/04/15		2.73MB	Share
AVR Change in substantial holding - Minderoo
30/03/15		53.15KB	Share
AVR Dispatch of Offer Document
30/03/15		221.8KB	Share
AVR Rights Issue - Sample Application Form
30/03/15		438.08KB	Share
AVR Non-Renounceable Right Issue Offer Document
30/03/15	PRICE SENSITIVE	279.86KB	Share
AVR Letter to Shareholders
30/03/15		779.43KB	Share
AVR Change of Director's Interest Notice
26/03/15		256.89KB	Share
AVR Appendix 3B - Placement & Exercise of Options
25/03/15		828.48KB	Share
AVR Non-Renounceable Right Issue Offer Document
20/03/15	PRICE SENSITIVE	561.15KB	Share
AVR Letter to Ineligible Shareholders
20/03/15		77.23KB	Share
AVR Letter to Eligible Shareholders
20/03/15		254.12KB	Share
AVR Letter to Optionholders
20/03/15		321.69KB	Share
AVR Admedus Investor Presentation
18/03/15		901.84KB	Share
AVR Appendix 3B - Rights Issue
18/03/15		724.88KB	Share
AVR Notice under Section 708AA
18/03/15		168.93KB	Share
AVR Admedus announces Placement and Rights Issue
18/03/15	PRICE SENSITIVE	290.29KB	Share
AVR Trading Halt
16/03/15	PRICE SENSITIVE	362.09KB	Share
AVR Admedus expands CardioCel market
12/03/15	PRICE SENSITIVE	277.83KB	Share
AVR Half Year Report
27/02/15	PRICE SENSITIVE	225.86KB	Share
AVR Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	387.46KB	Share
AVR Admedus End of Year Update
24/12/14	PRICE SENSITIVE	289.38KB	Share
AVR Appendix 3X - Initial Director's Interest Notice
05/12/14		234.28KB	Share
AVR HPV Vaccine Heads to the Clinic
24/11/14	PRICE SENSITIVE	299.01KB	Share
AVR Results of Annual General Meeting
14/11/14		338.14KB	Share
AVR AGM - Presentation to Shareholders
14/11/14		800.65KB	Share
AVR Admedus receives Originating Process
12/11/14		295.91KB	Share
AVR Change in substantial holding
10/11/14		1.57MB	Share
AVR Appendix 3B - Options
05/11/14		623.7KB	Share
AVR CardioCel gains special access in Singapore
03/11/14	PRICE SENSITIVE	339.88KB	Share
AVR Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	289.96KB	Share
AVR Cancellation of Unlisted Options
27/10/14		139.48KB	Share
AVR Appendix 3B - Exercise Options
27/10/14		668.52KB	Share
AVR CardioCel granted Medical Device Licence in Canada
20/10/14	PRICE SENSITIVE	291.33KB	Share
AVR Annual Report to shareholders
14/10/14		4.43MB	Share
AVR Proxy Form
14/10/14		329.65KB	Share
AVR Notice of Annual General Meeting
14/10/14		173.41KB	Share
AVR Chairman's Letter to Shareholders
14/10/14		110.83KB	Share
AVR Admedus to showcase CardioCel at EACTS Annual Meeting
10/10/14		281.34KB	Share
AVR Director Appointments
10/10/14		302.69KB	Share
AVR Appendix 3B
07/10/14		668.66KB	Share
AVR Admedus announces further data from HSV-2 Trial
02/10/14	PRICE SENSITIVE	427.97KB	Share
AVR Becoming a substantial holder
30/09/14		1.38MB	Share
AVR Appendix 3B
03/09/14		800.95KB	Share
AVR Annual Report to shareholders and Appendix 4E
28/08/14	PRICE SENSITIVE	1.53MB	Share
AVR Admedus ships CardioCel to US from new facility
14/08/14	PRICE SENSITIVE	322.99KB	Share
AVR Appendix 4C - quarterly
30/07/14	PRICE SENSITIVE	291.14KB	Share
AVR Admedus increases holding in Admedus Vaccines
24/07/14	PRICE SENSITIVE	342.65KB	Share
AVR Appendix 3B - Exercise of Options
22/07/14		800.55KB	Share
AVR Admedus End of Financial Year Update
26/06/14	PRICE SENSITIVE	353.61KB	Share
AVR Change of Director's Interest Notice
12/06/14		230.85KB	Share
AVR Change of Director's Interest Notices
11/06/14		274.06KB	Share
AVR Appendix 3B - Share Purchase Plan
11/06/14		770.4KB	Share
AVR Admedus SPP well supported
06/06/14		292.02KB	Share
AVR Appendix 3B - Exercise of options
23/05/14		726.94KB	Share
AVR Appendix 3B - ESOP
22/05/14		725.08KB	Share
AVR Change in substantial holding
22/05/14		489.62KB	Share
AVR Security Purchase Plan - Sample Application Form
19/05/14		330.23KB	Share
AVR Security Purchase Plan
19/05/14		1.55MB	Share
AVR Security Purchase Plan - Chairman's Letter
19/05/14		1.23MB	Share
AVR Appendix 3B - Placement & Notice under Section 708A
19/05/14		753.75KB	Share
AVR Admedus announces Placement and SPP
12/05/14	PRICE SENSITIVE	341.69KB	Share
AVR Trading Halt
08/05/14	PRICE SENSITIVE	354.98KB	Share
AVR CardioCel Sales Update - First sales order for the US
07/05/14	PRICE SENSITIVE	280.17KB	Share
AVR CardioCel 6 year data shows no calcification
01/05/14	PRICE SENSITIVE	277.68KB	Share
AVR AHZ 4C March 2014 quarter
24/04/14	PRICE SENSITIVE	407.37KB	Share
AVR Appendix 3B - Options
28/03/14		734.18KB	Share
AVR Investor Presentation
25/03/14		1.95MB	Share
AVR Appendix 3B - Options & Notice under Section 708A
07/03/14		766.87KB	Share
AAI +PRX ADS ADO AEH CQE AFJ AGI AVR AJD ALK ALU AMX ANI AOH AQG AQP ARP PRN ASZ ATU AVG AXZ BGA BNO BOL BTR BYI CAJ CCU CLE CFU COF CPL CRH CTP CUE CVO DCG DDR DLX DML DSH DYL EAX K2P EPW EQX WJA EVR EWC FLK FLN RHK FND NOU FSA GAP GBG GBT GCS GDI ETM GHC GID GJT GNG GOW GDA GRY GUF GXY HIG HPI IAG E88 ICN ICQ IDC DXI IPP ISN JHX JPR KPL KRL KRM VBC LSA MCE MCR MCS MEO AZT LCL SYM MNW SVR MOY MPO MRP MVP MYE NCM NCR NEA NEN NEU NSE NSR NXS OFX OMH OZL PAN PBD ATH PCL PEN PGH OVT IMM QAN AX1 REA RKN RXP SAO SBB SDF SDM SEH SHJ SIV KLS SLR SMX SWL TAP TBR TFC TGP TGZ AUK UGL VAH VED VEI VET VLW VOC VTG WBA WDS XRO ZNZ ZSPS&P DJ Indices Announces March Quarterly Rebalance
07/03/14		98KB	Share

REFRESH

First 8 9 10 11 12

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.05		Change 0.450(8.04%)		Mkt cap ! $93.65M

Open	High	Low	Value	Volume
$5.98	$6.07	$5.83	$280.8K	46.71K

Buyers (Bids)

No.	Vol.	Price($)
1	95	$6.02

Sellers (Offers)

Price($)	Vol.	No.
$6.31	200	1

View Market Depth

No.	Vol.	Price($)
1	95	6.020
1	124	6.000
1	2000	5.710
1	943	5.300
1	613	5.240

Price($)	Vol.	No.
6.310	200	1
6.380	3500	1
6.400	449	1
6.500	1230	3
6.600	3823	2

Last trade - 15.49pm 25/08/2025 (20 minute delay)


Last $6.03		Change 0.450 ( 7.68 %)
Open	High	Low	Volume
$5.95	$6.03	$5.95	2183
Last updated 14.05pm 25/08/2025 ?

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available